The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis Clinical Trial

— iPeer2Peer  

Official title:

The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03116763
• Other study ID #: 1000054878
• Status: Completed
• Phase: N/A
• Start date: March 28, 2017
• Est. completion date: April 16, 2023

Study information

• Verified date: November 2023
• Source: The Hospital for Sick Children
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).

Description:

Arthritis is a common childhood illness that makes everyday activities hard for young people. It is a long-lasting illness that can make you feel pain, tired and emotionally upset. This can make it hard for children and teens to see friends and do the activities that they like. The goal of this project is to find out if the newly developed peer mentoring program called iPeer2Peer helps teens with arthritis take better care of their illness and feel more connected to other people with arthritis. The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 164
• Est. completion date: April 16, 2023
• Est. primary completion date: April 16, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 18 Years

Eligibility

Inclusion Criteria:

• males and females 12-18 years old

• rheumatologist-diagnosed JIA according to ILAR criteria

• able to speak and read English

• access to a computer, smartphone or tablet capable of using free Skype software (note:

participants who do not have adequate Internet access will be provided with portable Internet sticks)

• willing and able to complete online measures.

Exclusion Criteria:

• significant cognitive impairments

• major co-morbid illnesses (medical or psychiatric conditions) likely to influence HRQL assessment

• participating in other peer support or self-management interventions.

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Juvenile
• Juvenile Idiopathic Arthritis

Intervention

Behavioral:
• iPeer2Peer Mentorship
10 sessions of 20-30 minute Skype calls conducted over 5-12 weeks.

Other:
• Active Comparator: Control Group
The control group will receive standard care but without the iPeer2Peer program.

Locations

Country	Name	City	State
Canada	Alberta Children's Hospital	Calgary	Alberta
Canada	The IWK Health Centre	Halifax	Nova Scotia
Canada	Children's Hospital - London Health Sciences	London	Ontario
Canada	Children's Hospital of Eastern Ontario (CHEO)	Ottawa	Ontario
Canada	The Hospital for Sick Children	Toronto	Ontario
Canada	BC Children's Hospital	Vancouver	British Columbia

Sponsors (4)

Lead Sponsor	Collaborator
The Hospital for Sick Children	Children's Hospital of Eastern Ontario, IWK Health Centre, Provincial Health Services Authority

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	TRANSITION-Q (measuring change)	14-item measure of self-management skills that is both reliable (internally consistent, test-retest) and valid (face, construct and content validity)	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	PedsQL Arthritis Module (measuring change)	Health-related quality of life	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	PROMIS Pain Interference (measuring change)	Pain	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	Screen for Child Anxiety Related Disorders (measuring change)	Emotional distress	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	Center for Epidemiologic Studies Depression Scale Revised (measuring change)	Emotional distress	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	Medical Issues, Exercise, Pain and Social Support Questionnaire (measuring change)	Disease knowledge	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	Children's Arthritis Self-Efficacy (measuring change)	Self-efficacy	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	PROMIS Pediatric Peer Relationship Scale (measuring change)	Perceived social support	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	AQoL-6D, interview (measuring change)	Cost utility analysis	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	Health service use and costs (measuring change)	Cost utility analysis	Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary	Mentor Behavior Scale (measuring change)	Mentor quality	Post-Intervention (approximately following 12 weeks of calls)
Secondary	PROMIS Adult Profile (measuring change)	For mentors only: mentor physical and emotional symptoms	At beginning of study and at end of study (approximately 3 years later)
Secondary	PROMIS Satisfaction with Social Roles and Activities (measuring change)	For mentors only: perceived social role satisfaction	At beginning of study and at end of study (approximately 3 years later)
Secondary	Chronic Disease Self-Efficacy Scale (measuring change)	For mentors only: self-efficacy	At beginning of study and at end of study (approximately 3 years later)
Secondary	Mentor interaction form	Record of interactions with mentees	Following completion of each mentee's calls (approximately following 12 weeks of calls)